WallStreetZenWallStreetZen

NASDAQ: CLDX
Celldex Therapeutics Inc Stock Ownership - Who owns Celldex Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Celldex Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Freddy A. JimenezSVP GENERAL COUNSEL2024-02-1320,000$2.78
$55.60kBuy
Freddy A. JimenezSVP GENERAL COUNSEL2024-02-134,166$9.02
$37.56kBuy
Samuel Bates MartinSVP AND CFO2024-01-0210,750$2.78
$29.88kBuy

1 of 1

CLDX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLDX insiders and whales buy or sell their stock.

CLDX Shareholders

What type of owners hold Celldex Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Thomas S. Paluck13.65%7,632,346$277.05MInsider
Fmr LLC12.61%7,050,409$255.93MInstitution
Wellington Management Group LLP11.59%6,476,561$235.10MInstitution
Blackrock Inc6.58%3,675,692$133.43MInstitution
Eventide Asset Management LLC6.49%3,630,013$131.77MInstitution
Rtw Investments LP6.20%3,463,201$125.71MInstitution
Polar Capital Holdings PLC5.61%3,135,871$113.83MInstitution
Vanguard Group Inc5.45%3,046,331$110.58MInstitution
Kynam Capital Management LP5.38%3,005,904$109.11MInstitution
Medarex Inc5.30%2,960,848$107.48MInsider

1 of 3

CLDX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLDX82.75%17.25%Net BuyingNet Buying
DYN65.80%34.20%Net SellingNet Selling
KYMR71.48%28.52%Net SellingNet Selling
NTLA68.92%31.08%Net SellingNet Selling
RCKT54.89%45.11%Net SellingNet Selling
View Top Biotech Stocks

Celldex Therapeutics Stock Ownership FAQ

Who owns Celldex Therapeutics?

Celldex Therapeutics (NASDAQ: CLDX) is owned by 109.09% institutional shareholders, 22.75% Celldex Therapeutics insiders, and 0.00% retail investors. Thomas S. Paluck is the largest individual Celldex Therapeutics shareholder, owning 7.63M shares representing 13.65% of the company. Thomas S. Paluck's Celldex Therapeutics shares are currently valued at $277.05M.

If you're new to stock investing, here's how to buy Celldex Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.